Greensboro, NC, United States of America

Matt Biggers

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Microvention, Inc.. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matt Biggers - Innovator in Hydrocephalus Treatment

Introduction

Matt Biggers is an accomplished inventor based in Greensboro, NC (US). He has made significant contributions to the field of medical technology, particularly in the treatment of hydrocephalus. His innovative approach has led to the development of a unique shunt system designed to manage excess cerebrospinal fluid (CSF) accumulation.

Latest Patents

Matt Biggers holds 1 patent for his invention titled "Treatment for Hydrocephalus." This patent describes a shunt system that utilizes various mechanical, electrical, or electromechanical concepts. The system is designed to either clean a portion of the shunt or customize CSF drainage, providing a more effective solution for patients suffering from this condition.

Career Highlights

Currently, Matt Biggers is employed at Microvention, Inc., a company known for its innovative medical devices. His work at Microvention has allowed him to focus on developing advanced solutions for neurological conditions, enhancing patient care and treatment outcomes.

Collaborations

Throughout his career, Matt has collaborated with talented individuals such as Joseph Rye and Jared A. Shimizu. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Matt Biggers is a notable inventor whose work in hydrocephalus treatment exemplifies the impact of innovation in medical technology. His contributions continue to advance the field and improve the lives of patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…